Akèy › Skleroderm Difize › Kansas › Kansas City
Etid klinik pou Skleroderm Difize nan Kansas City, KS
4 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Ap rekriteFaz 2
- EncompaSSc site in Kansas City, KS, Kansas City
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- University of Kansas Medical Center, Kansas City
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Chicago, IL7 etid
- Ann Arbor, MI7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Baltimore, MD5 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Pittsburgh, PA4 etid
- New Orleans, LA4 etid
- Philadelphia, PA4 etid
- Phoenix, AZ3 etid
Lòt etid nan Kansas City
- Maladi poumon entèstisyèl14 etid
- Maladi kadyovaskilè14 etid
- Ensifizyans kadyak13 etid
- Fibroz sistik13 etid
- Obèsite13 etid
- Kansè nan tete12 etid
- Kansè pwostat12 etid
- Kansè vejik12 etid
- Leksemi mieloïd egi11 etid
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon11 etid
- BPCO9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.